RXQ Compounding LLC recalls diazePAM 5 MG/ML INJECTION SOLUTION (C-IV) SYR, 2 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens
Recalled August 14, 2019 · FDA recall D-1648-2019 · RXQ Compounding
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
N/A
Sold at
Nationwide USA
Description
Lack of Assurance of Sterility
Product
diazePAM 5 MG/ML INJECTION SOLUTION (C-IV) SYR, 2 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0929-02
Manufacturer(s)
RXQ Compounding LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →